Mutation Specific Treatments for Inherited Retinal Diseases

Area of Science:

• Ophthalmology
• Genetics
• Molecular Biology

Background:

• Inherited retinal diseases (IRDs) represent a significant cause of vision impairment.
• Current gene replacement therapies face limitations with large causative genes and specific mutation types.

Purpose of the Study:

• To review mutation-specific genetic therapy strategies for IRDs.
• To highlight approaches in clinical trials and pre-clinical development.

Main Methods:

• Discussion of CRISPR-Cas9 gene editing technology.
• Review of post-transcriptional gene silencing using antisense oligonucleotides.
• Mention of pre-clinical approaches: RNA editing, RNA interference, and TRADs.

Main Results:

• CRISPR-Cas9 and antisense oligonucleotides have advanced to human clinical trials for IRDs.
• Several other mutation-specific therapies are under investigation in pre-clinical stages.

Conclusions:

• Mutation-specific genetic therapies offer a promising new frontier for treating IRDs.
• These advanced techniques address limitations of traditional gene replacement, expanding therapeutic possibilities.